EUVIMED · CrossrefJournal
BJC Reports
ISSN 2731-9377 · Springer Science and Business Media LLC
Latest articles
Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma
Human papillomavirus 16 genomic variation in head and neck cancer: a systematic review with structural and functional annotation
Homologous recombination deficiency (HRD) testing of high-grade serous carcinoma using cytological samples
Urinary volatilomics using liquid-liquid extraction and gas chromatography-mass spectrometry (GC-MS) combined with machine learning algorithms as a tool for diagnosis and surveillance of urothelial bladder cancer
Frequency of exercise and cancer-related fatigue among patients with lymphoma
Therapeutic challenges of a renal collision tumour comprising clear cell renal cell carcinoma and metastatic breast carcinoma: a case report
Role of consolidative surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC): Princess Margaret Cancer Centre experience
Outcomes from the NHS-Galleri trial: the good, the bad, and the uncertain
Peribronchial cuffing: an underrecognized pattern of prostate carcinoma metastases to the lung
Long-term outcomes and GVHD in allogeneic hematopoietic cell transplantation abroad: a 14-year UAE multi-center cohort
Biomass burning, PM2.5 peaks, and trends in lung adenocarcinoma diagnoses: an ecological study in São Paulo State, Brazil
Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide
Outcome measurement tools in pediatric oncology palliative care: a scoping review of domains, validation and contextual relevance
Prognostic significance of intratumoral neutrophil extracellular traps in pulmonary pleomorphic carcinoma: comparison with adenocarcinoma
Duty of care: amplifying the impact of planetary health research at oncology conferences
The evolution of non-surgical management in stage III non-small cell lung cancer
Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies
Beckwith-Wiedemann syndrome multiomic analysis of hepatoblastoma uncovers unique tumour heterogeneity and cellular landscapes, including transition cells leading to tumour formation
4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma
Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide
Significance and challenges in dissecting cancer-bacteriome interactions
Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibition
Remarkable response of metaplastic breast cancer to a novel targeted AKT inhibitor TAS-117 in a Cowden syndrome patient: a case report
Disparities in blood cancer survival in the UK 2009–2019: national cohort studies
A comprehensive genomic framework for identifying genes predisposing to homologous recombination repair-deficient breast or ovarian cancer
Editorial: focus on the COMET trial
Correction: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic
Commentary: With Regards to the WISDOM trial
Obesity-associated gene mutations across cancer types: a pan-cancer analysis of TCGA data
Understanding the preferences of younger women for the delivery of a service to predict breast cancer risk: a discrete choice experiment
EUVIMED